Agreement between commercially available ELISA and in-house Luminex SARS-CoV-2 antibody immunoassays
Abstract Serological diagnostic of the severe respiratory distress syndrome coronavirus 2 (SARS-CoV-2) is a valuable tool for the determination of immunity and surveillance of exposure to the virus. In the context of an ongoing pandemic, it is essential to externally validate widely used tests to as...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c3dbe39f18724f4eaa11861c19674e89 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|